Eve Health Group Stock Current Valuation
| EVE Stock | 0 0.00 0.00% |
Valuation analysis of EVE Health Group helps investors to measure EVE Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, EVE Health's Total Cashflows From Investing Activities is comparatively stable compared to the past year. Other Cashflows From Investing Activities is likely to gain to about 603.9 K in 2024, whereas Cash is likely to drop slightly above 100.9 K in 2024. Fundamental drivers impacting EVE Health's valuation include:
Price Book 4.3092 | Enterprise Value 5.2 M | Enterprise Value Ebitda (1.05) | Price Sales 2.4719 | Enterprise Value Revenue 2.4572 |
Overvalued
Today
Please note that EVE Health's price fluctuation is very steady at this time. Calculation of the real value of EVE Health Group is based on 3 months time horizon. Increasing EVE Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
EVE Health's intrinsic value may or may not be the same as its current market price of 0, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 8.4E-4 | Hype 0.001 |
The intrinsic value of EVE Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EVE Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EVE Health Group helps investors to forecast how EVE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EVE Health more accurately as focusing exclusively on EVE Health's fundamentals will not take into account other important factors: EVE Health Group Company Current Valuation Analysis
EVE Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current EVE Health Current Valuation | 5.24 M |
Most of EVE Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EVE Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, EVE Health Group has a Current Valuation of 5.24 M. This is 99.97% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The current valuation for all Australia stocks is 99.97% higher than that of the company.
EVE Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EVE Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EVE Health could also be used in its relative valuation, which is a method of valuing EVE Health by comparing valuation metrics of similar companies.EVE Health is currently under evaluation in current valuation category among its peers.
EVE Fundamentals
| Return On Equity | -0.71 | |||
| Return On Asset | -0.3 | |||
| Profit Margin | (0.89) % | |||
| Operating Margin | (0.75) % | |||
| Current Valuation | 5.24 M | |||
| Shares Outstanding | 5.27 B | |||
| Shares Owned By Insiders | 51.24 % | |||
| Price To Book | 4.31 X | |||
| Price To Sales | 2.47 X | |||
| Revenue | 2.13 M | |||
| Gross Profit | 827.83 K | |||
| EBITDA | (1.51 M) | |||
| Net Income | (1.55 M) | |||
| Cash And Equivalents | 1.1 M | |||
| Total Debt | 74.85 K | |||
| Cash Flow From Operations | (1.11 M) | |||
| Beta | 0.94 | |||
| Market Capitalization | 5.27 M | |||
| Total Asset | 2.52 M | |||
| Retained Earnings | (34.8 M) | |||
| Working Capital | 1.22 M | |||
| Net Asset | 2.52 M |
About EVE Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EVE Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EVE Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EVE Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.